Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Collisson

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Plos One|November 19, 2014
RADIA: RNA and DNA integrated analysis for somatic mutation detectionAmie J Radenbaugh, Singer Ma, Adam Ewing, et al.
Cancer Research|September 11, 2013
Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progressionChristy L Trejo, Shon Green, Victoria Marsh, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
Gastroenterology|October 10, 2021
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 AgonismHonglin Jiang, Tristan Courau, Joseph Borison, et al.
Molecular Cancer Therapeutics|October 28, 2003
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cellsEric A Collisson, Celina Kleer, Mei Wu, et al.
Pancreas|June 13, 2022
The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline TestingEvan J Walker, Amie M Blanco, Julia Carnevale, et al.
Abdominal Radiology (New York)|December 31, 2024
AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognosticationAjith Antony, Sovanlal Mukherjee, Yan Bi, et al.
Genome Medicine|October 12, 2013
A robust prognostic signature for hormone-positive node-negative breast cancerObi L Griffith, François Pepin, Oana M Enache, et al.
Molecular Cancer Therapeutics|August 7, 2013
Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinomaOlga K Mirzoeva, Eric A Collisson, Peter M Schaefer, et al.
Familial Cancer|September 30, 2018
Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinomaEvan J Walker, Julia Carnevale, Christina Pedley, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Plos One|November 19, 2014
RADIA: RNA and DNA integrated analysis for somatic mutation detectionAmie J Radenbaugh, Singer Ma, Adam Ewing, et al.
Cancer Research|September 11, 2013
Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progressionChristy L Trejo, Shon Green, Victoria Marsh, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
Gastroenterology|October 10, 2021
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 AgonismHonglin Jiang, Tristan Courau, Joseph Borison, et al.
Molecular Cancer Therapeutics|October 28, 2003
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cellsEric A Collisson, Celina Kleer, Mei Wu, et al.
Pancreas|June 13, 2022
The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline TestingEvan J Walker, Amie M Blanco, Julia Carnevale, et al.
Abdominal Radiology (New York)|December 31, 2024
AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognosticationAjith Antony, Sovanlal Mukherjee, Yan Bi, et al.
Genome Medicine|October 12, 2013
A robust prognostic signature for hormone-positive node-negative breast cancerObi L Griffith, François Pepin, Oana M Enache, et al.
Molecular Cancer Therapeutics|August 7, 2013
Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinomaOlga K Mirzoeva, Eric A Collisson, Peter M Schaefer, et al.
Familial Cancer|September 30, 2018
Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinomaEvan J Walker, Julia Carnevale, Christina Pedley, et al.
Pageof 10